Orphelia Pharma Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 10

Employees

  • Latest Deal Type
  • M&A

Orphelia Pharma General Information

Description

Developer of pediatric drugs designed to improve the health and well-being of severely disabled children. The company's pediatric medicines development platform develops new medicinal products in the field of rare and pediatric diseases like neuro-pediatric epilepsy, neurodegenerative diseases, and metabolic diseases, enabling healthcare professionals to develop essential medicines for oncology and CNS diseases.

Contact Information

Formerly Known As
TargeOn
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 85 Boulevard Saint-Michel
  • 75005 Paris
  • France
+33 01
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Parent Company
Vertical(s)
Corporate Office
  • 85 Boulevard Saint-Michel
  • 75005 Paris
  • France
+33 01

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Orphelia Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition Completed Generating Revenue
6. Grant 11-May-2022 Completed Generating Revenue
5. Later Stage VC 12-Mar-2020 Completed Generating Revenue
4. Later Stage VC 20-Dec-2017 Completed Generating Revenue
3. Accelerator/Incubator 07-Aug-2015 Completed Generating Revenue
2. Angel (individual) 12-Sep-2007 $341K $341K Completed Startup
1. Corporate 01-Jan-2007 Completed Startup
To view Orphelia Pharma’s complete valuation and funding history, request access »

Orphelia Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
To view Orphelia Pharma’s complete cap table history, request access »

Orphelia Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of pediatric drugs designed to improve the health and well-being of severely disabled children. The company's
Pharmaceuticals
Paris, France
10 As of 2024

Waltham, MA
 

Stockholm, Sweden
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Orphelia Pharma Competitors (50)

One of Orphelia Pharma’s 50 competitors is Ardelyx, a Formerly VC-backed company based in Waltham, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ardelyx Formerly VC-backed Waltham, MA
Calliditas Therapeutics Formerly VC-backed Stockholm, Sweden
Dicerna Pharmaceuticals Formerly VC-backed Lexington, MA
Pfizer (Vienna) Corporation Vienna, Austria
Pfizer Pakistan Corporation Karachi, Pakistan
You’re viewing 5 of 50 competitors. Get the full list »

Orphelia Pharma Patents

Orphelia Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3613436-A1 Oral suspension of temozolomide Active 13-Dec-2018
EP-3613436-B1 Oral suspension of temozolomide Active 13-Dec-2018
US-11730732-B2 Oral suspension of temozolomide Active 13-Dec-2018
US-20200188390-A1 Oral suspension of temozolomide Active 13-Dec-2018
ES-2877116-T3 Temozolomide oral suspension Active 13-Dec-2018 A61K9/0095
To view Orphelia Pharma’s complete patent history, request access »

Orphelia Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Orphelia Pharma Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bpifrance Sovereign Wealth Fund
Cemag Invest Family Office Minority
Laboratoires Pierre Fabre Corporation Minority
Octalfa Venture Capital Minority
PAF Kapital Angel Group Minority
To view Orphelia Pharma’s complete investors history, request access »

Orphelia Pharma FAQs

  • When was Orphelia Pharma founded?

    Orphelia Pharma was founded in 2007.

  • Where is Orphelia Pharma headquartered?

    Orphelia Pharma is headquartered in Paris, France.

  • What is the size of Orphelia Pharma?

    Orphelia Pharma has 10 total employees.

  • What industry is Orphelia Pharma in?

    Orphelia Pharma’s primary industry is Pharmaceuticals.

  • Is Orphelia Pharma a private or public company?

    Orphelia Pharma is a Private company.

  • What is Orphelia Pharma’s current revenue?

    The current revenue for Orphelia Pharma is .

  • How much funding has Orphelia Pharma raised over time?

    Orphelia Pharma has raised $8.04M.

  • Who are Orphelia Pharma’s investors?

    Bpifrance, Cemag Invest, Laboratoires Pierre Fabre, Octalfa, and PAF Kapital have invested in Orphelia Pharma.

  • Who are Orphelia Pharma’s competitors?

    Ardelyx, Calliditas Therapeutics, Dicerna Pharmaceuticals, Pfizer (Vienna), and Pfizer Pakistan are some of the 50 competitors of Orphelia Pharma.

  • Who acquired Orphelia Pharma?

    Orphelia Pharma was acquired by Orphalan.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process